Trial Profile
A Randomized, Parallel- Group Comparison Study of DE-089 Ophthalmic Solution in Patients With Dry Eye (Comparison With 0.1% Sodium Hyaluronate Ophthalmic Solution) - A Multinational Study -
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Aug 2020
Price :
$35
*
At a glance
- Drugs Diquafosol (Primary) ; Hyaluronic acid
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Santen Pharmaceutical
- 15 Aug 2014 New trial record
- 13 Nov 2012